LADONNA OSBORNE: Open Payments
NPI 1952382426 · TAZEWELL, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$416 in 28 payments from 10 companies in 2025. Trend: 2023 $683 · 2024 $421 · 2025 $416
Food & beverage: $416
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $135 |
| AstraZeneca Pharmaceuticals LP | 2 | $114 |
| Lilly USA, LLC | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Ardelyx, Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $17 |
| Astellas Pharma US Inc | 1 | $17 |
| PFIZER INC. | 1 | $14 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: AIRSUPRA, UBRELVY, VRAYLAR, MOUNJARO, CAPLYTA, Auvelity, IBSRELA, Rybelsus.
Industry payments across VA — which companies pay providers there.
